Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Ethnopharmacol ; 253: 112082, 2020 May 10.
Article in English | MEDLINE | ID: mdl-31310829

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Eriobotrya japonica leaves has a very long history of medicinal use as an anti-inflammatory and antitussive agent for bronchial inflammation. AIM OF THE STUDY: The aim of this study was to evaluate the anti-inflammatory activities of Eriobotrya japonica (EJ) leaf water extract in an ovalbumin (OVA)-induced murine asthma model and human tracheal smooth muscle cell (HTSMC). MATERIALS AND METHODS: Mice were sensitized by intra peritoneal OVA and challenged with nebulized OVA. EJ extract was administered orally at various dose. Bronchoalveolar lavage fluid (BALF) was quantified for nitric oxide (NO), eosinophil peroxidase (EPO), interleukin (IL)-4, IL-13 level and immunoglobulin (Ig) E was quantified in serum. Lung tissue sections were stained with hematoxylin and eosin for assessment of inflammatory cell infiltration whereas mucus production and goblet cell hyperplasia were studied by periodic acid schiff staining. Western blot was done for analysis of pERK1/2 expression and NFκB translocation in HTSMC whereas iNOS and COX-2 expression in RAW264.7 cell. RESULTS: EJ significantly reduced the levels of BALF's NO, EPO, MMPs, IL-4, IL-13, and serum IgE. It also decreases inflammatory cell infiltration and mucus production. EJ also attenuated the proliferation of HTSMC, inhibits overexpression of ERK 1/2 and translocation of NFκB in HTSMC as well as iNOS and COX-2 expression in RAW 264.7 cell. CONCLUSION: Present study suggest that, EJ effectively protects against allergic airway inflammation thus possessing potential therapeutic option for allergic asthma management.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Asthma/drug therapy , Eriobotrya/chemistry , Plant Extracts/pharmacology , Animals , Anti-Asthmatic Agents/isolation & purification , Anti-Asthmatic Agents/pharmacology , Anti-Inflammatory Agents/isolation & purification , Asthma/pathology , Bronchoalveolar Lavage Fluid , Cytokines/metabolism , Disease Models, Animal , Female , Inflammation/drug therapy , Inflammation/pathology , Mice , Mice, Inbred BALB C , Ovalbumin , Plant Leaves , RAW 264.7 Cells
2.
Chem Biol Interact ; 257: 54-60, 2016 Sep 25.
Article in English | MEDLINE | ID: mdl-27474068

ABSTRACT

A series of acylated xanthone C-glucosides were identified from the methanolic extract of whole Iris rossii Baker. The major constituent was characterized as 6'-O-acetyl mangiferin (OAM), and complete structure elucidation was carried out using 2D NMR (COSY, HSQC, and HMBC) and LC-IT-TOF-MS analyses. The present study is the first to report the anti-inflammatory effects of 6'-O-acetyl mangiferin from Iris rossii Baker on the lipopolysaccharide (LPS)-induced inflammatory response in RAW264.7 macrophage cells. OAM strongly suppressed protein expression of inducible nitric oxide (iNOS) and cyclooxygenase-2 (COX-2), thereby inhibiting the production of nitric oxide (NO), prostaglandin E2 (PGE2), and cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß), and interleukin-6 (IL-6). Furthermore, OAM inhibited the LPS-induced phosphorylation of ERK, JNK, and p38, which led to the blockade of nuclear factor-kappa B (NF-κB) and inhibitor kappa B (IκB)-α activation. These results suggest that the anti-inflammatory effects of OAM may be attributed to the downregulation of COX-2 and iNOS via the suppression of NF-κB and the MAPK signaling pathway in RAW264.7 macrophages.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Iris Plant/chemistry , NF-kappa B/metabolism , Signal Transduction/drug effects , Xanthones/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Cyclooxygenase 2/drug effects , Cyclooxygenase 2/metabolism , Lipopolysaccharides/pharmacology , Mice , Mitogen-Activated Protein Kinases/metabolism , Nitric Oxide Synthase Type II/drug effects , RAW 264.7 Cells , Xanthones/chemistry , Xanthones/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...